Hjem › Atopisk dermatitis (eczem)
Atopisk dermatitis (eczem) kliniske forsøg rekrutterer i USA
62 studier for Atopisk dermatitis (eczem) rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- New York City, NY13 studier
- Washington, DC11 studier
- Los Angeles, CA11 studier
- San Diego, CA10 studier
- San Antonio, TX10 studier
- Miami, FL9 studier
- Birmingham, AL9 studier
- Troy, MI8 studier
- Dallas, TX8 studier
- Huntington Beach, CA8 studier
- Sacramento, CA8 studier
- Tampa, FL7 studier
- Indianapolis, IN7 studier
- Pittsburgh, PA7 studier
- Philadelphia, PA6 studier
- Chicago, IL6 studier
- Santa Monica, CA6 studier
- Sugar Land, TX6 studier
- Phoenix, AZ6 studier
- Santa Clarita, CA6 studier
- Las Vegas, NV5 studier
- St. Petersburg, FL5 studier
- Portland, OR5 studier
- Charleston, SC5 studier
- Little Rock, AR5 studier
- Fremont, CA4 studier
- Harrisburg, PA4 studier
- Louisville, KY4 studier
- Cleveland, OH4 studier
- Arlington, TX4 studier
- Morgantown, WV4 studier
- Portsmouth, NH4 studier
- Miami Gardens, FL4 studier
- Newton, MA4 studier
- San Francisco, CA4 studier
- Fargo, ND4 studier
- Coral Springs, FL4 studier
- Baltimore, MD4 studier
- Ann Arbor, MI4 studier
- Houston, TX3 studier
Efter delstat
- Alabama9 studier
- Arizona7 studier
- Arkansas8 studier
- Californien30 studier
- Colorado4 studier
- Florida18 studier
- Georgia9 studier
- Idaho4 studier
- Illinois10 studier
- Indiana9 studier
- Kentucky4 studier
- Maryland16 studier
- Massachusetts6 studier
- Michigan14 studier
- Missouri7 studier
- Nebraska4 studier
- Nevada6 studier
- New Hampshire5 studier
- New Jersey3 studier
- New York16 studier
- North Carolina8 studier
- North Dakota4 studier
- Ohio10 studier
- Oregon6 studier
- Pennsylvania13 studier
- South Carolina10 studier
- Texas18 studier
- Utah4 studier
- Virginia5 studier
- Washington3 studier
- West Virginia4 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Natural History and Genetics of Food Allergy and Related Conditions
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
1 Day – 99 Years · Alle køn · Opdateret 2. okt. 2026 · NCT02504853Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RekruttererFase 1
Alder 12 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT07262983Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 29. sep. 2026 · NCT07453602A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 72 · Alle køn · Opdateret 29. sep. 2026 · NCT06808477This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
RekruttererObservationsstudie
Alder 12 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06947993Effects of Treatments on Atopic Dermatitis
RekruttererFase 2Frivillige med god helbredstilstand velkomne
Alder 2 til 50 · Alle køn · Opdateret 28. sep. 2026 · NCT01631617Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07298395First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07527923A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
RekruttererFase 3
Alder 2 til 11 · Alle køn · Opdateret 25. sep. 2026 · NCT06807281A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 25. sep. 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07003425Metabolic Profiling of Immune Responses in Immune-mediated Diseases
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 22. sep. 2026 · NCT04864886Studies of Skin Microbes in Healthy People and in People With Skin Conditions
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 til 100 · Alle køn · Opdateret 16. sep. 2026 · NCT00605878Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
RekruttererObservationsstudie
Alder 12 til 89 · Alle køn · Opdateret 15. sep. 2026 · NCT07645820The Impact of Dietary Salt on the Severity of Eczema
RekruttererFase 4Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT07447063The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
RekruttererFase 4Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07487831Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Rekrutterer
Alder 13 til 17 · Alle køn · Opdateret 8. sep. 2026 · NCT07746427A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
RekruttererFase 2/3
Alder 18 til 80 · Alle køn · Opdateret 4. sep. 2026 · NCT07355075A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07223697A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 28. aug. 2026 · NCT07599813CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT04504955Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
RekruttererFase 2
Alder 3 til 21 · Alle køn · Opdateret 26. aug. 2026 · NCT03835767Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
RekruttererObservationsstudie
Alder 12 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT06899204Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.